Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Hervé Tiriac, Associate Project Scientist, University of California-San Diego
New approaches to prioritize treatment strategies are urgently needed to
improve survival and quality of life for pancreatic cancer patients.
Combined genomic, transcriptomic, and therapeutic profiling of
patient-derived organoids can identify molecular and functional subtypes
of pancreatic cancer, predict therapeutic responses and facilitate
precision medicine for pancreatic cancer patients.
|
|
Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/LondonStem Cells in Drug Discovery Tox and Organoids 2019Stem Cells in Drug Discovery Tox and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
.jpg)
